CLOSE X
GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
29.27 -0.26(-0.88%) NAV as on 29 Jan 2026
-4.19 % 1 M
0.03 % 1 Y
20.27 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.30

As on 31 Dec, 2025
age-icon Age :

6 yrs 6 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

837.41 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.62

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2025
Others 1.19 %
Equity 98.81 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.47 %
Apollo Hospitals Enterprise Ltd.7.14 %
Cipla Ltd.6.08 %
Torrent Pharmaceuticals Ltd.4.71 %
JB Chemicals & Pharmaceuticals...4.51 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs76.78
Hospital & Healthcare Services19.69
Business Support1.43
Chemicals0.90
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 29-Jan-2026)18.2216.3626.4529.3929.27
Net Assets(Rs Crores) (as on 29-Jan-2026) 515.33 428.44 699.55 814.95 837.41
Scheme Returns(%)(Absolute)12.40-10.2661.3810.031.04
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7570/7611/9032/10287/113

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity29.27-0.26(-0.88%)NAV As on 29 Jan, 202610-Jul-2019Inception Date837.41AUM In Cr.0.03%1Y20.27%3Y13.20%5Y17.78%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.11-0.33(-0.88%)NAV As on 29 Jan, 202613-Jul-2018Inception Date6,455.55AUM In Cr.1.48%1Y25.39%3Y16.96%5Y18.96%Since Inception
Nippon India Pharma Fund(G)Very HighEquity481.82-5.31(-1.09%)NAV As on 29 Jan, 202605-Jun-2004Inception Date8,264.71AUM In Cr.1.58%1Y20.15%3Y14.60%5Y19.58%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors